A systematic review and economic evaluation of pegylated liposomal doxorubicin hydrochloride for ovarian cancer.

C Forbes, J Wilby, G Richardson, L Mather, M Sculpher, R Riemsma

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-143
Number of pages	143
Journal	Health Technology Assessment
Volume	6(23):
Publication status	Published - 2002

Access to Document

@article{abd5d25d0ea944eb8e03b990d4cd0139,

title = "A systematic review and economic evaluation of pegylated liposomal doxorubicin hydrochloride for ovarian cancer.",

author = "C Forbes and J Wilby and G Richardson and L Mather and M Sculpher and R Riemsma",

year = "2002",

language = "English",

volume = "6(23):",

pages = "1--143",

journal = "Health technology assessment",

issn = "1366-5278",

publisher = "NHS National Institute for Health Research",

}

TY - JOUR

T1 - A systematic review and economic evaluation of pegylated liposomal doxorubicin hydrochloride for ovarian cancer.

AU - Forbes, C

AU - Wilby, J

AU - Richardson, G

AU - Mather, L

AU - Sculpher, M

AU - Riemsma, R

PY - 2002

Y1 - 2002

M3 - Article

SN - 1366-5278

VL - 6(23):

SP - 1

EP - 143

JO - Health technology assessment

JF - Health technology assessment

ER -